Skip to main content
SpringerLink
Log in

Analysis of the results of sleeve gastrectomy for morbid obesity and the role of ghrelin

  • Review Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

To evaluate the effectiveness of laparoscopic sleeve gastrectomy (LSG), a relatively new bariatric surgical procedure associated with duodenal switch (DS), we analyzed the findings of ten published studies on LSG. No relationship was found between the excess weight loss and the size of the bougie or the follow-up period. The amount of gastric fundus removed may be an important consideration because most ghrelin-producing cells are in the fundus; however, there is insufficient evidence that lowered ghrelin is the sole reason for the resulting weight loss after this procedure. Laparoscopic sleeve gastrectomy is still considered experimental by many, but the initial results are promising, with one study even suggesting long-term results comparable with those of other bariatric procedures. Ghrelin may play a role in the weight loss associated with LSG, but is unlikely to be the sole reason for its success.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Marceau P, Biron S, Bourque RA, Potvin M, Hould FS, Simard S. Biliopancreatic diversion with a new type of gastrectomy. Obes Surg 1993;3(1):29–35.

    Article  PubMed  Google Scholar 

  2. Gagner M, Steffen R, Biertho L, Horber F. Laparoscopic adjustable gastric banding with duodenal switch for morbid obesity: technique and preliminary results. Obes Surg 2003;13(3):444–449.

    Article  PubMed  Google Scholar 

  3. Frezza EE. Laparoscopic vertical sleeve gastrectomy for morbid obesity. The future procedure of choice? Surg Today 2007;37:275–281.

    Article  PubMed  Google Scholar 

  4. Roa PE, Kaidar-Person O, Pinto D, Cho M, Szomstein S, Rosenthal RJ, et al. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg 2006;16:1323–1326.

    Article  PubMed  Google Scholar 

  5. Regan JP, Inabnet WB, Gagner M, Pomp A. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 2003;13:861–864.

    Article  PubMed  CAS  Google Scholar 

  6. Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as first stage procedure for super-obese patients. Obes Surg 2005;15:612–617.

    Article  PubMed  Google Scholar 

  7. Mognol P, Chosidow D, Marmuse JP. Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg 2005;15:1030–1033.

    Article  PubMed  Google Scholar 

  8. Han MS, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy at 1 year in morbidly obese Korean patients. Obes Surg 2005;15:1469–1475.

    Article  Google Scholar 

  9. Bernante P, Foletto M, Busetto L, Pomerri F, Pesenti FF, Pelizzo MR, et al. Feasibility of laparoscopic sleeve gastrectomy as a revision procedure for prior laparoscopic gastric banding. Obes Surg 2006;16:1327–1330.

    Article  PubMed  Google Scholar 

  10. Langer FB, Bohdjalian A, Felberbauer FX, Fleischmann E, Reza Hoda MA, Ludvik B, et al. Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obes Surg 2006;16:166–171.

    Article  PubMed  Google Scholar 

  11. Almogy G, Crookes, PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg 2004;14:492–497.

    Article  PubMed  Google Scholar 

  12. Deitel M, Greenstein RJ. Recommendations for reporting weight loss. Obes Surg 2003;13(2):159–160.

    Article  PubMed  Google Scholar 

  13. Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005;15(7):1024–1029.

    Article  PubMed  CAS  Google Scholar 

  14. Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005;15:1024–1029.

    Article  PubMed  CAS  Google Scholar 

  15. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, et al. Stomach is a major source of circulation ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001;86:4753–4758.

    Article  PubMed  CAS  Google Scholar 

  16. Lin E, Gletsu N, Fugate K, McClusky D, Gu LH, Zhu JL, et al. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Arch Surg 2004;139:780–784.

    Article  PubMed  Google Scholar 

  17. Broglio F, Koetsveld PV, Benso A, Gottero C, Prodam F, Papotti M, et al. Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. J Clin Endocrinol Metab 2002;87:4829–4832.

    Article  PubMed  CAS  Google Scholar 

  18. Norrelund H, Hansen TK, Orskov H, Hosoda H, Kojima M, Kangawa K, et al. Ghrelin immunoreactivity in human plasma is suppressed by somatostatin. Clin Endocrinol (Oxf) 2002;57:539–546.

    Article  CAS  Google Scholar 

  19. Frezza EE, Wachtel MS, Chiriva-Internati. The multiple faces of glucagon-like peptide 1-obesity, appetite, and stress: what is next? A Review. DDS 2007;52(3):643–649.

    CAS  Google Scholar 

  20. Frezza, EE. Are we closer in finding the treatment for type II diabetes mellitus in morbid obesity — are the incretins the key to success? Obes Surg 2004;14(7):999–1005.

    Article  PubMed  Google Scholar 

  21. Meier JJ, Gallwitz B, Schmidt WE, Nauck MA. Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives. Eur J Pharmacol 2002;440:269–279.

    Article  PubMed  CAS  Google Scholar 

  22. Christou NV, Look D, McLean AP. Pre and post-prandial plasma ghrelin levels do not correlate with satiety or failure to achieve a successful outcome after Roux-en-Y gastric bypass. Obes Surg 2005;15(7):1017–1023.

    Article  PubMed  Google Scholar 

  23. Ikezaki A, Hosoda H, Ito K, Iwama S, Miura N, Matsuoka H, et al. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes 2002;51(12):3408–3411.

    Article  PubMed  CAS  Google Scholar 

  24. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 2003;52:1098–1103.

    Article  PubMed  CAS  Google Scholar 

  25. Lin E, Gletsu N, Fugate K, McClusky D, Gu LH, Zhu JL, et al. Insulin-associated downregulation of ghrelin expression in the morbidly obese and type-2 diabetes (DM). J Am Coll Surg 2003;197(suppl 3):S9.

    Google Scholar 

  26. Lee CM, Feng JJ, Cirangle PT, Jossart GH. Laparoscopic vertical sleeve gastrectomy for morbid obesity in 216 patients: report of two-year results. Presented at SAGES, Dallas, Texas, April 28, 2006.

Download references

Author information

Authors and Affiliations

  1. Division of General Surgery, Department of Surgery, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX, 79430, USA

    Eldo E. Frezza

  2. Department of Microbiology and Immunology, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX, 79430, USA

    Maurizio Chiriva-Internati

  3. Department of Pathology, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX, 79430, USA

    Mitchell S. Wachtel

Authors
  1. Eldo E. Frezza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maurizio Chiriva-Internati
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mitchell S. Wachtel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frezza, E.E., Chiriva-Internati, M. & Wachtel, M.S. Analysis of the results of sleeve gastrectomy for morbid obesity and the role of ghrelin. Surg Today 38, 481–483 (2008). https://doi.org/10.1007/s00595-007-3648-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-007-3648-8

Key words

Search

Navigation